medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2013, Number 4

<< Back Next >>

Acta Pediatr Mex 2013; 34 (4)

Ophthalmologic findings in patients with inborn errors of metabolism

Guevara-Márquez YC, Vela-Amieva M, Juárez EJC, Ordaz FJC, Belmont-Martínez L

Language: Spanish
References: 31
Page: 212-224
PDF size: 722.76 Kb.


ABSTRACT

In patient with inborn errors of metabolism (IEM), the presence of characteristic findings in ophthalmic assessment are important for the diagnosis. The presence of cataracts, cherry-red spot, corneal opacities, corneal crystals, lens dislocation, gyrate atrophy, etc., are some of the ocular abnormalities present in certain IEM. The role of the ophthalmologist in the evaluation of patients with IEM is essential. We describe the most frequent ocular findings in patients with different IEM, which are a diagnostic aid for ophthalmologists and pediatricians.


REFERENCES

  1. Rajappa M, Goyal A, Kaur J. Inherited metabolic disorders including the eye: a clinic-biochemical perspective. Eye. 2010;24:507-18.

  2. Vela AM, Belmont ML, Fernández LC, Ramírez FC, Ibarra GI. Frecuencia de enfermedades metabólicas congénitas susceptibles de ser identificadas por el tamiz neonatal. Acta Pediatr Mex. 2009;30(3):56-62.

  3. Barth PG, Duran M. The eye as window to inborn errors of metabolism. J Inherit Metab Dis. 2003;26:229-44.

  4. Singh R, Ram J, Kaur G, Prasad R. Galactokinase deficiency induced cataracts in Indian infants: Identification of 4 novel mutations in GALK gene. Current Eye Res. 2012;37(10):949-54.

  5. Coss KP, Doran PP, Owoeye C, Codd MB, Hamid N, Mayne PD et al. Classical galactosemia in Ireland: incidence, complications and outcomes of treatment. J Inherit Metab Dis. 2013;36:21-7.

  6. Tsilou E, Zhou M, Gahl W, Sieving PC, Chan CC. Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: Report of a case and review of the literature. Surv Ophthalmol. 2007;52(1):97-105.

  7. Sodi A, Loannidis A, Pitz S. Ophthalmological manifestations of Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, editors; 2006. p. 26. Disponible en: http://www.nbci.nlm.nih.gov/books/NBK11599/

  8. Beltrán BK, Ríos GB, Gutiérrez AB, Noriega SD, Figueroa LE. Manifestaciones oftalmológicas en pacientes mexicanos con enfermedad de Fabry. Arch Soc Esp Oftalmol. 2012;(232):1-3.

  9. Bustos ZM, Ortega RC, De la Fuente TM, Aguilar MG, Brechtel M, Hernández T y cols. Catarata congénita. Rev Hosp Gral Dr M Gea González. 2001;4(3):57-61.

  10. Shleikhzade S, Kade C, Keysor B, Stuhrmann M, Arslan-Kirchner M, Rybczynski M, Bernhardt AM, et al. Analysis of phenotype and genotype information for the diagnosis of Marfan syndrome. Clin Genet. 2012;82(3):240-7.

  11. Patterson MC, Hendriksz CT, Watterfang M, Sedel F, Vanier MT, Wijburg F, NP-C Guidelines Working Group. Recommendations for the diagnosis and management of Niemann-Pick disease type C: An update. Mol Genet Metab. 2012;106:330-44.

  12. Marrocos AR, Gondim RR, Alves PF, Ferreira RB, Nogueira FN. “Cherry red spot” in a patient with Tay-Sachs disease: case report. Arq Bras Oftalmol. 2009;72(4):537-9.

  13. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1(4):1-12.

  14. Doimo M, Desbats MA, Baldoin MC, Lenzini E, Basso G, Murphy E, et al. Functional analysis of missense mutations of OAT, causing gyrate atrophy of choroid and retina. Human Mutat. 2013;34(1):229-36.

  15. Walter JH, Christodoulou J. Costeff optic atrophy syndrome: New clinical case and novel molecular findings. J Inherit Metab Dis. 2008;(suppl 2):S419-23.

  16. Saudubray JM, Desguerre I, Sedel F, Charpentier C. A clinical approach to inherited metabolic diseases. En: Fernandes J, Saudubray JM, Van del Berghe G, Walter J (eds). Inborn Metabolic Diseases. 4ª ed. Germany: Springer; 2006. p.45-6.

  17. Alcántara OM, Belmont ML, Vela AM, González DA. Analysis of the CTNS Gene in Nephropathic Cystinosis in Mexican Patients: Report of four Novel Mutations and Identification of a false Positive 57- kb Deletion Genotype with LDM-2/EXON 4MultiplexPCR Assay. Genet Test. 2008;12(3):409-14.

  18. Traber GM, Baumgartner MB, Schwarz UM, Pangalu AM, Donath MY, Landau KM. Subacute bilateral visual loss in Methylmalonic Acidemia. Neuro-Ophthal J. 2011;31(4):344-6.

  19. Santillán AE, Revilla EN, Belmont ML, Fernández LC, Guillén LS, Ibarra GI y cols. Tratamiento de urgencia de la acidemia metilmalónica. Acta Pediatr Mex 2012;33(1):48-51.

  20. Williams ZR, Hurley EP, Altiparmak UE, Feldon SE, Arnold GL, Eggerberg E, et al. Late onset optic neuropathy in methylmalonic and propionic acidemia. Am J Ophthalmol. 2009;147(5):929-33.

  21. Alcorn DM, Fredrick DR. Ophthalmic features of primary oxalosis after combined liver/kidney transplantation. Br J Ophthalmol. 2000;84(11):1326-7.

  22. Froissart R, Diraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buran A, et al. Glucose-6 phosphatase deficiency. Ortphanet J Rare Dis. 2011; :6-27.

  23. Kahlschütter A, Santer R, Lukas Z. A child with night blindness. Preventing serious symptoms of Refsum disease. J Child Neurol. 2012;25(5):654-6.

  24. Cañueto J, Girós M, Cirina S, Pi-Castán G, Artigas M, García-Dorado J, et al. Clinical, molecular and biochemical characterization of nine Spanish families with Conraid-Hunermann-Haple Syndrome: new insights into X-linked dominant chondrodysplasia punctate with a comprehensive review of the literature. Br J Dermatol. 2012;166(4):830-8.

  25. Gail SC, Ashworth JL. Ocular manifestations as key features for diagnosing mucopolysaccharidosis. Rheumatol. 2011;(Suppl 5):v34-40.

  26. Jackson CR, Pennesi ME. Retinal dystrophy in 2 brothers with α-Mannosidosis. Arch Ophthalmol. 2011;129(6):798-804.

  27. Kodama H, Fujisawa C, Bhadhprasat W. Inherited copper transport disorders: Biochemical mechanisms, diagnosis and treatment. Curr Drug Metabol. 2012;13(3):237-50.

  28. Gharbiya M, Moramarco A, Castori M, Parisi F, Celletti C, Marenco M, et al. Ocular features in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type: a clinical and in vivo confocal microscopy study. Am J Ophthalmol. 2012;154(3):593-600.

  29. Barraquer RI, Barraquer E. Manifestaciones corneales no inflamatorias en las enfermedades sistémicas. Annals d´Oftalmol. 2005;13(4):208-24.

  30. Mason DM, DeBarber AE, Bock CJ, Anadiotis DO, Merkens LS, Steiner RD, et al. Cerebrotendinous Xanthomatosis: A treatable disease with juvenile cataracts as a presenting sign. Arch Ophthalmol. 2011;129(8):1087-8.

  31. Online Mendelian inheritance in man. Johns Hopkins University. Online Catalog of human genes and genetic disorders. Consultado: 31 de Octubre del 2012. Disponible en: http://omim.org/.




2020     |     www.medigraphic.com